OMEROS CORP Inventory, Finished Goods, Net of Reserves
OMEROS CORP (OMER) had Inventory, Finished Goods, Net of Reserves of $184.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2021-11-09
- 2021-09-30: Inventory, Finished Goods, Net of Reserves $184.00K.
- 2021-06-30: Inventory, Finished Goods, Net of Reserves $387.00K.
- 2021-03-31: Inventory, Finished Goods, Net of Reserves $544.00K.
- 2020-12-31: Inventory, Finished Goods, Net of Reserves $784.00K.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2021-09-30 | $184.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $387.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $544.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $784.00K 10-Q · filed 2021-11-09 |
| 2020-09-30 | $666.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $606.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $726.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $718.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $751.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $586.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $301.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.00K 10-K · filed 2020-03-02 |
| 2017-12-31 | $360.00K 10-K · filed 2018-03-01 |
| 2017-09-30 | $343.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $267.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $163.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $173.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $54.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $120.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $176.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $221.00K 10-K · filed 2017-03-16 |
| 2014-12-31 | $568.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |